Antibody-RNA Conjugates represent a significant advancement in the treatment of challenging and rare diseases with unmet medical need.

miRecule, a biotechnology company developing RNA therapies, and GBI Biomanufacturing, a CDMO, entered a strategic partnership to advance the development and clinical supply of miRecule’s Antibody-RNA ...

Vantaca, the leading community association management software provider, is thrilled to announce the addition of four distinguished executives to its team: Tom Arnett as Chief Strategy Officer, John ...

Wrike, a leader in intelligent work management and an STG portfolio company, today announced the completion of its acquisition of Klaxoon, a provider of visual collaboration solutions, from Eurazeo, ...

Brooke Rollins attends a Senate Agriculture, Nutrition, and Forestry Committee hearing on her nomination for Secretary of Agriculture, Thursday, Jan. 23, 2025, in Washington. (AP Photo/Jacquelyn ...

This Feb. 9, 2024 photo shows a Walgreens in Bradenton, Fla. Walgreens booked a better-than-expected fiscal first quarter, but the drugstore chain lost $265 million as it closed U.S. stores and ...

While the access to combination treatments problem is nothing new, its sheer magnitude means it has, to date, gone unsolved. But now, an initiative spearheaded by Takeda is starting to shift the dial.

BREAKING NEWS The Nobel Assembly at the Karolinska Institutet has today decided to award the 2024 Nobel Prize in Physiology or Medicine to Victor Ambros and Gary Ruvkun for the discovery of ...